Abingworth LLP has raised £225 million from investors for its tenth life sciences fund that will provide venture capital to companies in Europe and the US. The proceeds exceeded the investment group’s target of £200 million. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
